Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$989K Buy
2,731
+155
+6% +$53.1K 0.21% 91
2026
Q1
$906K Sell
2,576
-233
-8% -$83.1K 0.22% 94
2025
Q4
$920K Buy
2,809
+196
+8% +$62.2K 0.22% 92
2025
Q3
$737K Buy
2,613
+17
+0.7% +$4.93K 0.19% 87
2025
Q2
$725K Sell
2,596
-75
-3% -$21.2K 0.2% 82
2025
Q1
$832K Sell
2,671
-54
-2% -$15.9K 0.25% 77
2024
Q4
$710K Buy
2,725
+3
+0.1% +$890 0.21% 82
2024
Q3
$877K Sell
2,722
-32
-1% -$10.5K 0.26% 77
2024
Q2
$860K Hold
2,754
0.27% 76
2024
Q1
$783K Buy
2,754
+44
+2% +$12.9K 0.26% 79
2023
Q4
$781K Buy
2,710
+713
+36% +$194K 0.29% 80
2023
Q3
$537K Buy
1,997
+495
+33% +$124K 0.22% 84
2023
Q2
$334K Buy
1,502
+400
+36% +$92.8K 0.14% 101
2023
Q1
$266K Buy
1,102
+150
+16% +$36.8K 0.12% 111
2022
Q4
$250K Buy
+952
New +$255K 0.12% 109

Other funds holding AMGN

Nikulski Financial's AMGN Position: Q2 2026 in Review

Nikulski Financial increased its Amgen (AMGN) stake by 6% in Q2 2026, buying an estimated $53.1K and bringing the position to 2,731 shares worth $989K. The position accounts for 0.21% of the portfolio, ranked #91.

Nikulski Financial first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Nikulski Financial held 2,731 shares of Amgen worth $989K as of Q2 2026.
  • Nikulski Financial bought 155 Amgen shares in Q2 2026, an estimated $53.1K.
  • Amgen made up 0.21% of Nikulski Financial's portfolio in Q2 2026, its #91 holding.
  • Nikulski Financial first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Nikulski Financial's 13F filing for Q2 2026, filed 28 Jul 2026.